Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial.

Sacktor, N; Miyahara, S; Deng, L; Evans, S; Schifitto, G; Cohen, B A; Paul, R; Robertson, K; Jarocki, B; Scarsi, K; Coombs, R W; Zink, M C; Nath, A; Smith, E; Ellis, R J; Singer, E; Weihe, J; McCarthy, S; Hosey, L; Clifford, D B

Sacktor, N; Miyahara, S; Deng, L; Evans, S; Schifitto, G; Cohen, B A; Paul, R; Robertson, K; Jarocki, B; Scarsi, K; Coombs, R W; Zink, M C; Nath, A; Smith, E; Ellis, R J; Singer, E; Weihe, J; McCarthy, S; Hosey, L; Clifford, D B.

Affiliation

Sacktor N; Department of Neurology, Johns Hopkins Bayview Medical Center, 4940 Eastern Ave., 301 Building, Suite 2100, Baltimore, MD 21224, USA. sacktor@jhmi.edu

Neurology ; 77(12): 1135-42, 2011 Sep 20.

Article in En | MEDLINE | ID: mdl-21900636

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Cognition Disorders / Minocycline Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2011 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google